Raymond James & Associates’s Ascendis Pharma A/S Ordinary Share ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $538K | Sell |
|
|||||
|
2024
Q2 | $564K | Buy |
|
|||||
|
2024
Q1 | $625K | Buy |
|
|||||
|
2023
Q4 | $417K | Sell |
|
|||||
|
2023
Q3 | $314K | Sell |
|
|||||
|
2023
Q2 | $315K | Sell |
|
|||||
|
2023
Q1 | $384K | Buy |
|
|||||
|
2022
Q4 | $423K | Sell |
|
|||||
|
2022
Q3 | $463K | Sell |
|
|||||
|
2022
Q2 | $438K | Sell |
|
|||||
|
2022
Q1 | $579K | Sell |
|
|||||
|
2021
Q4 | $4.03M | Buy |
|
|||||
|
2021
Q3 | $4.55M | Buy |
|
|||||
|
2021
Q2 | $3.42M | Buy |
|
|||||
|
2021
Q1 | $3.11M | Buy |
|
|||||
|
2020
Q4 | $3.53M | Buy |
|
|||||
|
2020
Q3 | $3.18M | Buy |
|
|||||
|
2020
Q2 | $232K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $218K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $341K | Buy |
|